Laser flash photolysis of the quinol ester 2b in O2-saturated aqueous phosphate buffer at pH 7.1 with excitation at 266 nm generates a transient intermediate with lambda(max) 460 nm that decays in a first-order manner with an aqueous solution lifetime of (170 +/- 10) ns at 22 degrees C. This intermediate is not affected by O2, but reacts rapidly with N3- with an apparently diffusion-limited rate constant of (6.6 +/- 0.2) x 10(9) M-1 s-1. Steady state photolysis of 2b yields the quinol 3b as a major reaction product with a yield of ca. 30-35% after correction for photolytic decomposition of 3b. This is the same product that is quantitatively produced by hydrolysis of 2b in the dark. Photolysis of 2b in the presence of 40 mM N3- completely suppresses the yield of 3b The photolytic intermediate is identified as the aryloxenium ion 1b, that was previously indirectly detected by N3--trapping during the hydrolysis of 2b, based on the chemical behavior of the transient and the quantitative agreement of the N3-/solvent selectivity ratio, kaz/ks, measured directly during the flash photolysis experiment, and indirectly by the azide clock procedure during the hydrolysis reaction. Other, as of yet unidentified, transients are produced during the photolysis reaction. A strong transient absorbance band observed at 360 nm decays in a biphasic manner with two first-order rate constants, neither of which are affected by O2 or N3-. The lifetimes of the two intermediates of ca. 12 and 75 mus are considerably longer than that of 1b. Another very short-lived species can be detected at early reaction times (

4-Acetoxy-4-(benzothiazol-2-yl)-2,5-cyclohexadien-1-one, 1, a quinol derivative that exhibits significant anti-tumor activity against human breast, colon, and renal cancer cell lines, undergoes hydrolysis in aqueous solution to generate an oxenium ion intermediate, 3, that is selectively trapped by N(3)(-) in an aqueous environment. The 4-(benzothiazol-2-yl) substituent slows the rate of ionization of 1 compared to analogues with 4-phenyl or 4-(p-tolyl) substituents, 4a or 4b. However, once generated, 3 is somewhat more selective than the 4-phenyl-substituted cation 5a. Calculations performed at the B3LYP/6-31G(d) level agree that the 4-(benzothiazol-2-yl) substituent does significantly stabilize 3. The structure of the major isolated azide adduct, 4-(6-azidobenzothiazol-2-yl)phenol, 9, confirms that the positive charge is highly delocalized in 3. The results of hydrolysis of 1 show that the 4-(benzothiazol-2-yl) substituent has a significant inductive electron-withdrawing effect as well as a significant resonance effect that is electron-donating. Photolysis of 1 in aqueous solution generates the quinol 2 as one of several photolysis products. The presence of the quinol suggests that photolysis also leads, in part, to generation of 3, but photoionization of 1 is significantly less efficient than is the case for the esters 4a and 4b. This study proves that 3 is generated by ionization of 1 in an aqueous environment. A significant number of other 2-benzothiazole derivatives that are not quinols, including ring-substituted derivatives of 2-(4-aminophenyl)benzothiazole 15, are under development as anti-tumor agents as well. The possible generation of the reactive intermediate 17 by hydrolysis of the putative metabolite 16 is under investigation.

Hyperoxia-induced lung injury adversely affects ICU patients and neonates on ventilator assisted breathing. The underlying culprit appears to be reactive oxygen species (ROS)-induced lung damage. The major contributor of hyperoxia-induced ROS is activation of the multiprotein enzyme complex NADPH oxidase. Sphingosine-1-phosphate (S1P) signaling is known to be involved in hyperoxia-mediated ROS generation; however, the mechanism(s) of S1P-induced NADPH oxidase activation is unclear. Here, we investigated various steps in the S1P signaling pathway mediating ROS production in response to hyperoxia in lung endothelium. Of the two closely related sphingosine kinases (SphKs)1 and 2, which synthesize S1P from sphingosine, only Sphk1(-/-) mice conferred protection against hyperoxia-induced lung injury. S1P is metabolized predominantly by S1P lyase and partial deletion of Sgpl1 (Sgpl1(+/-)) in mice accentuated lung injury. Hyperoxia stimulated S1P accumulation in human lung microvascular endothelial cells (HLMVECs), and downregulation of S1P transporter spinster homolog 2 (Spns2) or S1P receptors S1P1&2, but not S1P3, using specific siRNA attenuated hyperoxia-induced p47(phox) translocation to cell periphery and ROS generation in HLMVECs. These results suggest a role for Spns2 and S1P1&2 in hyperoxia-mediated ROS generation. In addition, p47(phox) (phox:phagocyte oxidase) activation and ROS generation was also reduced by PF543, a specific SphK1 inhibitor in HLMVECs. Our data indicate a novel role for Spns2 and S1P1&2 in the activation of p47(phox) and production of ROS involved in hyperoxia-mediated lung injury in neonatal and adult mice.